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Abstract: Xenotransplantation using pig tissues and organs is under development in order to alleviate
the increasing shortage of human transplants. Since xenotransplantation may be associated with the
transmission of porcine microorganisms to the human recipient, the donor pigs should be carefully
analyzed, especially for the presence of potentially zoonotic viruses. Göttingen Minipigs (GöMP)
are potential donors of islet cells for the treatment of diabetes. Despite the fact that all animals
produced at Ellegaard Göttingen Minipigs A/S carry porcine endogenous retroviruses (PERVs) in their
genome and that very few animals were infected with porcine cytomegalovirus (PCMV), hepatitis E
virus (HEV) and porcine lymphotropic herpesvirus (PLHV), no transmission of these viruses was
observed in a preclinical trial transplanting GöMP islet cells into cynomolgus monkeys. Using a new
comprehensive strategy, we then analyzed an isolated subpopulation of Göttingen Minipigs which
remained at the University of Göttingen. We concentrated on 11 xenotransplantation-relevant viruses
and combined co-incubation assays with susceptible human target cells and molecular biological
methods to evaluate the risk posed by PERV. All animals in Göttingen carry PERV-A, PERV-B, and
PERV-C in their genome but they are not infected with PCMV, PLHV and HEV. The difference may be
explained by selection of negative animals and/or de novo infection. The PERV copy number was
established using ddPCR (93 copies) and a human-tropic PERV-A/C was found released from PBMCs
of one animal with a high expression of PERV-C.
Keywords: porcine viruses; xenotransplantation; porcine endogenous retroviruses (PERV); porcine
cytomegalovirus (PCMV); hepatitis E virus (HEV); porcine lymphotropic herpesvirus (PLHV); porcine
circovirus (PCV)
1. Introduction
Göttingen Minipigs (GöMP) are well characterized and broadly used in biomedical research [1–3].
GöMP are the result of crossbreeding Minnesota Minipigs, Vietnamese potbelly pigs and German
landrace pigs at the University of Göttingen, Germany [4]. Later the commercial production of GöMP
was performed at Ellegaard Göttingen Minipigs A/S (Denmark) in a full-barrier specified pathogen-free
Viruses 2020, 12, 38; doi:10.3390/v12010038 www.mdpi.com/journal/viruses
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(SPF) facility. At Ellegaard the animals are screened twice a year for numerous microorganisms
including 27 bacteria, 16 viruses, three fungi and four parasites [3]. Among the porcine viruses,
PERVs pose a special risk for xenotransplantation, since all pigs carry proviruses in their genome [5].
PERV-A and PERV-B are capable of infecting human cells and are present in the genome of all
pigs, whereas PERV-C infects only pig cells and is present in the genome of many, but not all pigs.
When we analyzed GöMP from Ellegaard for the prevalence and expression of PERVs, we found that
all animals carry PERV-A, PERV-B and PERV-C [6]. However, recombinant PERV-A/Cs were not found
in five investigated Ellegaard GöMP. PERV-A/C has been found in some organs of other pig breeds
carrying PERV-A and PERV-C, they are the product of recombination and de novo integration into
somatic pig cells of living pigs and never have been found in the germ line of pigs [7]. PERV-A/C
are characterized by higher replication rates compared with their parental viruses [8] and further
passaging on human cells increased their virus titer due to duplications of repeats in the LTR [9]. Using
droplet digital PCR, 82 copies of PERV were found in GöMP from Ellegaard [10]. The expression
of PERV, analyzed as full-length mRNA using reverse transcriptase (RT)-PCR with specific primers,
was found moderate to low, the expression increased after stimulation of PBMCs with the mitogen
phytohemagglutinin (PHA) [6]. However, release of human-tropic PERV, able to infect human 293
cells was not observed in these experiments [6]. Together with the screening performed at Ellegaard,
49 groups of pathogens (more than 88 individual microorganisms) were analyzed and found absent in
GöMP [11]. Using highly sensitive RT-PCR and immunological methods we found hepatitis E virus
(HEV), porcine cytomegalovirus (PCMV) and porcine lymphotropic herpesviruses (PLHV) in a very
small number of GöMP from Ellegaard [11,12]. HEV was shown to be transmitted via the placenta,
making elimination more difficult [11]. At present HEV is the only known zoonotic porcine virus able
to infect humans and to induce disease [13,14]. PCMV was found to reduce significantly the survival
time of pig xenotransplants in non-human primates and therefore may also pose a risk when pig
organs will be transplanted into humans (for review see [15]). Despite the presence of low amounts
of PCMV, PLHV and HEV in very few GöMPs from Ellegaard, no transmission of these viruses was
observed in a preclinical trial transplanting islet cells from these pigs into cynomolgus monkeys [16].
Here we analyze a subpopulation of the GöMP founder population which remained and was
bred isolated from the Ellegaard GöMP at the University of Göttingen. Interestingly, in this population
all animals were free of PCMV and HEV and therefore in these points different from the GöMP
at Ellegaard. The analysis was based on a new screening strategy and was concentrating on
xenotransplantation-relevant viruses, first of all PERVs.
2. Materials and Methods
2.1. Pig Holding Including Absence of Vaccination and Food Additives
The Relliehausen breeding colony is housed in a conventional indoor stable with specific pathogen
free status, located on the research farm of the University of Göttingen, near Dassel, Germany.
The facility is functionally separated into mating, farrowing, weaning and general maintenance units.
Admission to the facility requires passing of a hygienic lock and use of in-house clothing. Animals
are fed a conventional fibre rich pelleted diet and straw from the adjunct fields is administered for
enrichment reasons. In case of disease, animals are treated according to veterinary standards, but
no regular vaccination scheme is employed. The colony is under a regular health monitoring which
involves testing for Actinobacillus pleuropneumoniae ApxII-toxin, pseudorabies (porcine herpesvirus 1,
PHV1), classical swine fever, Mycoplasma hyponeumoniae, porcine reproductive and respiratory
syndrome virus (PRRSV, Betaarterivirus suid), Sarcoptes scabiei var. suis, salmonella, Pasteurella
multocida and several endoparasites. Animal keepers who also work with other pigs must maintain a
two-day quarantine before re-entering the facility. In principle, no animals are brought or returned
into the facility.
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2.2. Blood and Isolation of PBMCs
Eleven animals of the Relliehausen breeding colony of different age and different
gender were tested repeatedly (Table 1). EDTA blood was taken vom the Vena jugularis
(permission number 33.9-42502-05-19A391, Niedersächsisches Landesamt für Verbraucherschutz
und Lebensmittelsicherheit) and shipped cooled at 4 ◦C. PBMCs were isolated using a Lymphocyte
Separation Medium 1077 (PromoCell, Heidelberg, Germany) gradient.
2.3. General Screening Strategy
Using blood and isolated PBMCs, a broad virological analysis of the GöMP was performed
(Figure 1).
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Figure 1. Schematic presentation of the screening strategy. Figure 1. Schematic presentation of the screening strategy.
2.4. DNA and RNA Isolation
DNA was extracted from sera, blood or PBMCs using different DNA extraction kits: DNeasy Blood
and Tissue kit (Qiagen GmbH, Hilden, Germany), and NucleoSpin Virus (Macherey-Nagel, Düren,
Germany). DNA was quantifiedand the 260 nm/280 nm ratio was determined using a NanoDrop
ND-1000 (Thermo Fisher Scientific Inc., Worcester, MA, USA). RNA was extracted from blood or cells
using RNeasy Mini kit (Qiagen GmbH, Hilden, Germany) following the manufacturer’s instructions.
Viruses 2020, 12, 38 4 of 19
Table 1. Overview of the screening of Göttingen Minipigs from the University Göttingen (blood was taken on 8 February 2019 and 1 March 2019, and for some animals
again on 14 May 2019 and 28 August 2019.
ID Sex Date of Birth Remarks
Virus
PCMV PERV PCV2 PCV3 PLHV-1 PLHV-2 PLHV-3 HEV
Real-Time
PCR
PERV-C
Real-Time
PCR
PERV-C
EnvC2
PCR
PERVpol
PCR PCR
Real-Time
PCR PCR PCR PCR ELISA
Real-Time
PCR
A M 8 June 2014 Father (sire) - + + + - - - - - - -
B F 14 May 2015 - + + + - - - - - - -
C F 17 October 2015 Mother (dam) - + + + - - - - - - -
D F 17 October 2015 - + + + - - - - - - -
E F 29 May 2016 - + + + - - - - - - -
F F 14 October 2026 - + + + - - - - - - -
G F 7 July 2017 Daughter (femaleoffspring) - + + + - - - - - - -
H M 25 October 2017 - + + + - - - - - - -
I M 14. January 2018 - + + + - - - - - - -
J F 31 May 2018 - + + + - - - - - - -
K F 23 June2018 - + + + - - - - - - -
+ means positive detection of the virus, - means absence of virus.
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2.5. PCR, RT-PCR and Real-Time PCR
PCR methods or reverse transcriptase PCR (RT-PCR) methods, respectively, (Table 2) were
performed to screen for HEV [11,17], PCMV [12,18], PCV2 [19], PCV3 [20], PLHV (-1, -2, -3) [11] as
described. Using a primer pair in the pol region of PERV (PERVpol) all PERV types were detected [21],
using specific primers for the envelope regions, PERV-C and PERV-A/C were detected [7,22]. To detect
expression of PERV, primers specific for PERVpol were used which detect the full-length mRNA.
The full-length mRNA encodes Gag and Pol proteins. Furthermore, using specific primers, spliced
mRNA was detected encoding the envelope proteins (Env) (Figure 2, Table 2) [23]. Finally, using
specific primer in the env region, the expression of PERV-C was analysed. In real-time PCRs porcine
GAPDH was used for normalisation (Table 2).
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Figure 2. (A), Genomic organisation of PERV proviruses, (B), transcription of the full-length mRNA
(coding for the Gag proteins and the enzymes) and the spliced mRNA (coding for the envelope proteins
only), (C), localisation of the primers P1, P2 and P3 to amplify the spliced mRNA by RT-PCR and length
of the amplicons [23] (Table 2). SD, splice donor; SA, splice acceptor; LTR, long terminal repeat; gag,
pol, env, sequences coding for the Gag, Pol and Env proteins; bp, base pairs.
2.6. Mitogen Stimulation and Co-Culture
Based on previous investigations showing that mitogen stimulation increases the expression of
PERV in pig PBMCs up to the release of infectious virus particles [6,24–26], PBMCs from the GöMP
were treated with 2.4 µ/mL, in some cases 9.6 µg/mL phytohemagglutinin-L (PHA-L, M5030, Biochrom
GmBH, Berlin, Germany) and the expression of PERV was analyzed at the mRNA level and by testing
release of human-tropic virus. In a co-incubation assay with human embryonic kidney 293 T cells,
which are highly susceptible to an PERV infection due to the absence of intracellular restriction factors
among them APOBEC3G [27], the ability of released virus particles to infect human cells was analysed
(Figure 1). The co-cultures were repeatedly splitted to remove the pig PBMCs and 293 T cells were
screened repeatedly for PERV infection by PCR. To make sure that there were no remaining pig cells a
PCR was performed screening for porcine GAPDH using specific primers (Table 2).
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Table 2. Primers and probes used for virus screening.
Primers Used Sequence 5′-3′ Nucleotide Position Accession Number Reference
Primers used for PCR
PLHV-1,-2 (747) fw
PLHV-1,-2 (747) rev
CAYGGTAGTATTTATTCAGACA
GATATCCTGGTACATTGGAAAG
21,146–21,167
21,488–21,467 AY170317.1 Ehlers B., 2002 [28]
PLHV-3 (905) fw
PLHV-3 (905) rev
ACAAGAGCCTTAGGGTTCCAAACT
GTGTCCAGTGTTGTAATGGATGCC
13,472–13,495
13,727–13,704 AY170316.1 Chmielewicz et al., 2003 [29]
PCV2 fw (F66)
PCV2 rev (B67)
GGTTTGTAGCCTCAGCCAAAGC
GCACCTTCGGATATACTGTCAAGG
567–546
152–175 KT868491.1 Mankertz et al., 2000 [30]
PERV env C.2 fw
PERV env C.2 rev
GATTAGAACTGGAAGCCCCAAGTGCTCT
TCTGATCCAGAAGTTATGTTAGAGGATGGT
9362–9389
9649–9620 AM229312 Dieckhoff et al., 2009 [26]
Primers and probes used to detect PERV-A/C
PERV-A-VRBF
PERV-C-TMR
PERV-C rev
CCTACCAGTTATAATCAATTTAATTATGGC
C TCAAACCACCCTTGAGTAGTTTCC
TATGTTAGAGGATGGTCCTGGTC
Wood et al., 2004 [7]
Dieckhoff et al., 2009 [26]
Primers and probes used for real-time PCR
PCV3 fw
PCV3 rev
PCV3 probe
AGTGCTCCCCATTGAACG
ACACAGCCGTTACTTCAC
FAM-ACCCCATGG-Zen-CTCAACACATATGACC-BHQ
1427–1444
1561–1544
1473–1449
KT869077 Palinski et al., 2016 [31]
pGAPDH fw
pGAPDH rev
pGAPDH probe
GATCGAGTTGGGGCTGTGACT
ACATGGCCTCCAAGGAGTAAGAHEX-CCACCAACCCCAGCAAGAGCACGC-BHQ
1083–1104
1188–1168
1114–1137
NM_001206359.1 Duvigneau et al., 2005 [32]
HEV fw
HEV rev
HEV probe
GGTGGTTTCTGGGGTGAC
AGGGGTTGGTTGGATGAA
FAM-TGATTCTCAGCCCTTCGC-BHQ
5261–5278
5330–5313
5284–5301
M73218. Jothikumar et al., 2006 [17]
PCMV fw PCMV rev PCMV
probe
ACTTCGTCGCAGCTCATCTGA GTTCTGGGATTCCGAGGTTG
FAM-CAGGGCGGCGGTCGAGCTC-BHQ Mueller et al., 2002 [33]
PERV pol fw
PERV pol rev
PERV pol probe
CGACTGCCCCAAGGGTTCAA
TCTCTCCTGCAAATCTGGGCC
FAM-CACGTACTGGAGGAGGGTCACCTG-BHQ
3568–3587
3803–3783
3655–3678
HM159246 Yang et al., 2015 [21]
Primers used to detect spliced mRNA
P1
P2
P3
TGCTGTTTGCATCAAGACCGC
ACAGACACTCAGAACAGAGAC
ATGGAGGCGAAGCTTAAGGGGA
Karlas et al. [23]
Primers and probes used for dd PCR
pGAPDH fw
pGAPDH rev
pGAPDH probe
TTCACTCCGACCTTCACCA
CCGCGATCTAATGTTCTCTTTC
HEX-CAGCCGCGTCCCTGAGACAC-BHQ
3951–3970
4022–4001
3991–3972 bp
396823 Yang et al., 2015 [21]
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2.7. Determination of the PERV Copy Number
Droplet digital PCR (ddPCR) was performed according to the manufacturer’s instructions (Bio-Rad,
Hercules, CA, USA, [http://www.bio-rad.com/de-de/applications-technologies/droplet-digital-pcr-
ddpcr-technology?ID=MDV31M4VY]) using a QX200 droplet generator and a QX100 droplet reader
(Bio-Rad). Purified genomic DNA from cultured cells (50 ng genomic DNA) was digested with MseI
(New England Biolabs, Ipswich, MA, USA) (20U) at 37 ◦C for 1 h. The ddPCR mix consisted of 10 µL
2× ddPCR Master mix, 1.8 µL of each 10 µM target primers (Table 2), 0.5 µL of each 10 µM probes
(FAM/HEX) (Table 2). The DNA digest had a concentration of 2.5 ng/µL and 2 µL corresponding to
5 ng digested DNA and water was added to a total volume of 20 µL. The following cycling conditions
were used: 10 min initial enzyme activation at 95 ◦C, 30 s denaturation at 94 ◦C, 1min annealing and
extension at 60 ◦C (40 cycles) and final 10 min enzyme deactivation at 98 ◦C using a Master cycler ProS
(Eppendorf). The temperature ramp rate was 2 ◦C per second.
2.8. Transmission Electron Microscopy
PERV-producing 293 T cells were fixed with 2.5% glutaraldehyde in 50 mM HEPES, pH 7.2.
The cells were harvested by scraping, pelleted at 2.000 g for 5 min at 4 ◦C, and washed twice with
HEPES. After washing, the cells were block-embedded by mixing equal amounts of pelleted cells and
low-melting-agarose (3%). Agarose-embedded cells were cut into small pieces (<1 mm), and postfixed
with osmium tetroxide (1% in double distilled H2O for 1 h), tannic acid (0.1% in 50 mM HEPES for
30 min), and uranyl acetate (2% in ddH2O for 2 h). The agarose-embedded cells were dehydrated in
a graduated ethanol series and finally embedded in Epon resin. Thin sections (60–70 nm) were cut
on a Leica-Ultracut ultramicrotome, mounted on naked 300 mesh copper grids, and counterstained
with uranyl acetate (2% in ddH2O for 20 min), followed by lead citrate (Reynolds’ solution for 3 min).
Ultrathin sections were stabilized with a thin layer of carbon evaporation and examined using a
JEM-2100 transmission electron microscope (JEOL) at 200 kV. Images were recorded using a Veleta
CCD camera (EMSIS).2.8. HEV ELISA.
To test for antibodies against HEV, the PrioCHECK HEV Antibody ELISA Kit, porcine (Applied
Biosystems) was used. Porcine plasma, the controls, which are included in the kit, and sera from
previous positive tested pigs are analysed. Recombinant hepatitis E virus antigens encoded by the
open reading frames (ORF) ORF 2 and ORF 3 of the genotypes 1 and 3 were coated on the ELISA plate.
After incubation of the samples with the antigen (60 min, 37 ◦C) a washing step followed. The anti–HEV
antibodies present in the sample were incubated with the peroxidase (POD)-labeled anti-pig IgG
conjugate (30 min, 37 ◦C) and the unbound conjugate was washed away. 3,3′,5,5′-tetramethylbenzidine
(TMB) substrate was used for color development, which was measured at a wavelength of 450 nm and
a reference filter at 620 nm.
3. Results
3.1. Brief History of Göttingen Minipgs
To date, the Göttingen Minipig (GöMP) is among the smallest commercially used pig breeds
in the world, and it has been under a well-documented breeding scheme since its foundation in the
1960s. Its beginnings date back to 1949, when first efforts to establish a breeding program for one of its
ancestors, the Minnesota Minipig, were undertaken by Prof. Winters and his co-workers at the Hormel
Institute in Austin, Minnesota [34]. With the goal to attain a pig of limited size for laboratory research,
they collected and crossed individuals from several small-sized, wild and feral breeds from the U.S.,
among them feral hogs from Alabama, Piney-Woods-Hogs from Louisiana, a boar, probably of the
genus Sus scrofa vittatus, from the Island of Santa Catalina, California, and Ras-n-Lansa pigs from Guam.
The resulting pigs were generally of small stature, but highly variable in body size and coat color.
Prof. Fritz Haring and his co-workers from the Institute of Animal Breeding and Genetics of the
Georg-August-University Göttingen, Germany, recognized the demand for a similar animal model in
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Europe, and were able to obtain five individuals from Minnesota in 1960. They crossed them with
Vietnamese Potbellied Pigs from zoological gardens in West and East Germany. In 1965, another four
Vietnamese Potbellied Pigs were acquired. The resulting crosses were small, of short stature, mostly
obese and of diverse coat color. German Landrace sires were introduced by artificial insemination
to introgress dominant white coat color. Several generations of reciprocal mating with minipigs
and strong selection for small body size eventually resulted in a uniformly white minipig, when the
herdbook was closed in 1969 [35].
The GöMP is nowadays bred in five genetically isolated sub-populations, four of them run by
licensees, in Germany, Denmark (two colonies), USA and Japan. This strategy is beneficial from a
market perspective, since location of production units close to the relevant markets reduces animal
transports, which is also highly beneficial from an animal welfare point of view. The units remain
isolated, since exchange of animals would harbor the risk of transferring diseases or hidden genetic
disorders. A recent study has shown that albeit being isolated for decades, all stocks are genetically
still highly similar due to a common breeding effort [36].
3.2. Screening for PERV-C
All GöMP from Göttingen were found positive for PERV-A and PERV-B (Figure 3). When the
animals were screened for PERV-C a PCR method and a real-time PCR were used (Table 1).
All 11 animals were found positive for PERV-C with both methods (Table 1) (Figure 3).
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3.3. Screening for PERV-A/C
Using specific primers (Table 2), the animals were screened for the prevalence of PERV-A/C in
the genome of PBMCs. For this, DNA was isolated from PBMCs at day 0 and after cultivation of the
PBMCs in culture medium in the presence or absence of PHA-L after 5 days. This experiment was
repeated in some cases (pig E and F) three times and in the case of pigs C and H two times. This means
three consecutive bleedings of pigs E and F were cultured with PHA-L and analyzed by PCR for
PERV-A/C prevalence. Using the primer pair PERV-A-VRBF/PERV-C-TMR, a PERV-A/C amplicon
(1200 bp) was found in PBMCs from pig F and J already on day 0, in PBMCs from animals C and K only
after 5 days stimulation (Figure 4). Using a reverse primer located inside the sequence amplified by
the above mentioned primers, a shorter amplicon was obtained confirming the presence of PERV-A/C
in PBMCs from animal F. Interestingly, using these primers in PBMCs from pig C, a specific sequence
was amplified, whereas the longer sequence with the other primer was not found, indicating that
the primer binding site for the primer PERV-C TMR is missing or mutated and that the PERV-A/C in
animal C has a different recombination breakpoint compared with that of animal F. PERV-A/C had not
been found in GöMP from Ellegaard [6].
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Figure 4. Detection of PERV-A/C proviruses in GöMP from the Göttingen University. PBMCs from
three consecutive bleedings (bleedings 2, 3 and 4) were isolated and tested at day 0 and after 5 days
of cultivation with PHA. Two primer pairs were used resulting in overlapping amplicons (Figure 2).
11 pigs (A–K) were analyzed, as well as a PERV-A/C plasmid PERV-A 14/220 ([37], AY570980) (P) and
as negative control (N) water.
3.4. Copy Number of PERV in the Genome
Using ddPCR the PERV copy number was determined. The copy number measured in the PBMCs
from blood of the GöMP from Göttingen was 93+/–9 per cell, the copy number in GöMP from Ellegaard
was 95+/–10, in both cas s using porcine GAPDH (pGAPDH) as reference (Figure 5). These data
were higher when compared with the copy umber in öMP from Ellegaard ported previously
(82+/–12) [10]. As a control the py number of PERV in PK-15 was determined: 42+/–1 copies. In a
publication a copy number of 30+/–1.6 was found, also using pGAPDH as reference [10].
As previously shown, the number of actin genes (ACTB) and GAPDH genes was not always two per
c ll as th oretically expected [10], and so we rep ated the analysis using ACTB as reference. Using this
setting, he m an PERV copy number in PBMCs from the GöMP from Götti gen was 77.91, and in
PK15 cells 42.53 (Figure 6). The ratio of the copy number in PK15 cells estimated using GAPDH
as reference gene (42 copies), to the opy number det rmined using ACTB (30 copies), is 1.4, suggesting
that in these cells approxiomately two GAPDH g nes and three ACTB genes are present. The situat on
is similar in th GöMP from Göttingen, the ratio of the copy number estimated using GAPDH as
referenc gene (93 copies), to the copy number determined using ACTB (72 copies), is 1.3. Theref re,
the copy nu ber of PERV depends on the copy numbers of the reference genes.
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Figure 5. Determination of the copy number of PERV in the genome of Göttingen Minipigs (GöMP)
from Ellegaard (E) and from the University of Göttingen (Gö) using GAPDH as reference. In addition,
PK15 cells were tested. Results under nu ber one (1) were published in Fiebig et al. [10], number two
(2) represent data obtained in this study together with the testing of GöMP from Göttingen.
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3.5. Expression of PERV
To study the expression of PERV, a RT-qPCR was performed using primers specific for the pol region.
This PCR measures the full-length mRNA of all PERVs. The full-length mRNA encodes the Gag and Pol
proteins. All animals expressed this mRNA in their freshly isolated PBMCs, animal E only at a very low
rate (Figure 7A). After stimulation with 2.4 µg/mL PHA-L the expression was high in PBMCs from pig F,
lower in PBMCs from pigs G, H, and I and low in the PBMCs from the other pigs (Figure 7A).Viruses 2020, 12, x FOR PEER REVIEW 12 of 21 
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Figure 7. Relative expression of all PERVs using primers specific for pol (A,C) and primers specific
for PERV-C env (B,D). (A), Expression of PERVpol at day zero (green column) and day 5 after PHA
stimulation (blue columns) relative to the expres ion i K15 cells. Eleven pigs (A, B, C, D, E, F, G H, I,
J and K) were tested. PBMCs from pigs A, B, D, G, I, J and K were tested once, the PBMCs from pigs
C and H were tested twice (two bleedings with independent PHA-L stimulations), the PBMCs from
pigs E and F six times (three different bleedings with independent PHA-L stimulations). In the case of
pigs A, B, D, G, I, J, and K no measurement at day 0 were performed. (B), expression of PERV-C at
day 0 compa d to the expr s i n of GAPDH, (C), relative expression of PERVpol compared with the
expression of PK15 cells on day 0 (d0) and day 5 (d5) after stimulation with PHA (PBMCs from animal
E, blue column, PBMCs from animal F, red column), (D), expression of PERV-C on day 0 (d0) and day 5
(d5) after stimulation with PHA-L compared to the expression of GAPDH (PBMCs from pig E, blue
column, PBMCs from pig F, red column). All error b rs i d cate s.e.m.
Using specific pri ers, the expression of PERV- was analyzed. The highest expression was found
in PBMCs from animals F and H, slightly lower in PBMCs from pigs A and E, and low in the other
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pigs (Figure 7B). The expression of PERV-C is of importance, because PERV-C is required in order to
generate PERV-A/C. High expression of PERV-C was found in PBMCs from the same animals showing
a high expression of full-length mRNA (pigs F and I). The other animals showed a low expression.
As shown previously, the expression of PERV increases after stimulation of PBMCs from pigs of
different strains with PHA [6,24,25]. These findings were confirmed here. Both the expression of the
full-length mRNA detected by PERV pol primers (Figure 7C) and the expression of PERV-C (Figure 7D)
increased in PBMCs from pig E and pig F. The increase in PBMCs from pig F is much higher when
compared with that from pig E. The expression of PERV-A/C increased also significantly (not shown).
The use of higher concentrations of PHA-L (9.6 µg/mL) did not results in higher PERV expression rated.
To screen for spliced mRNA, which is encoding for the Env proteins, specific primers were used
as shown in Figure 2. Spliced mRNA was not found in freshly isolated PBMCs, but in cultured and
stimulated PBMCs after 5 days with exception of pig A (Table 3).
Table 3. Expression of PERV in stimulated and unstimulated PBMCs from GöMP.
ID
PERV Expression
Release of Virus 3
Non-Stimulated, Non-Cultured Non-Stimulated, Cultured Stimulated, Cultured
FL 1 S 2 FL 1 S 2 FL 1 S 2
A + - + - + - -
B + - + + + + -
C + - + + -+ + -
D + - + + -+ + -
E + - + + + + -
F + - + + + + +
G + - + + + + -
H + - + + + + -
I + - + + + + -
J + - -+ + + + -
K + - + + + + -
1 FL, full length mRNA; 2 S, spliced mRNA; 3 human-tropic virus infecting 293 T cells.
3.6. Release of Human-Tropic PERV
To study the release of infectious virus particles, mitogen-stimulated PBMCs from all GöMP
were co-cultured with human 293 cells, which are highly sensitive for PERV infection (Figure 1).
Only PBMCs from a single animal, pig F, released particles able to infect 293 T cells (Table 1). The virus
was found released in three different experiments, e.g., three consecutive bleedings obtained from the
pig F with independent co-cultivations with 293 T cells. The virus, designated F-PERV, was able to
infect uninfected 293 cells and was identified as PERV-A/C by PCR (Figure 4).
Electron microscopy analysis of 293 cells in the 14th passage after co-cultivation with PBMCs from
pig F showed typical type C viruses. Mature, maturing (Figure 8A,B) and budding viruses (Figure 8C)
were found.
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Sequencing of the amplicon obtained in the PERV-A/C specific PCR confimed that it is a PERV-A/C
(Figure 9). The region of recombination between PERV-A and PERV-C was identified between nt 205 and
249 of the sequenced region which is between nt 721 and 811 of the env gene and a second breakpoint
was found between 596 and 657. Therefore, the organisation of the sequence is PERV-A-C-insert-A-C.Viruses 2020, 12, x FOR PEER REVIEW 14 of 21 
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Figure 9. Sequence align of PERV-A, PERV-C, and two PERV-A/C, the PERV-A 14/220 described
by Bartosch et al. [37] (AY570980) and the PERV-A/C 50 analyzed in our laboratory (AY953542) [9,23,38],
as well as the virus isolated from GöMP F (GM-F). The primer PERV-A VRBF (blue line) and the
primer PERV-C-TMR (not shown, ranging from nt 1288–1263) (Table 2) were used for amplification and
sequencing of the PERV-A/C env sequence. The primer PERV-C rev (blue line) was also used for the
detection of PERV-A/C (Figure 4). The sequences marked yellow represent the potential regions of
recombination, the orange bar indicate an insertion. N, any nucleotide; M, A or C, W, A or T.
3.7. Screening for PCMV, HEV, PLHV, PCV2 and PCV3
Using specific primers and testing the blood of the animals or the isolated and cultivated PBMCs
for PCMV, HEV, PLHV-1, PLHV-2, PLHV-3, PCV2 and PCV3, all samples were found negative (Table 1).
Based on these results differences between the GöMP at Ellegaard and at the University of Göttingen
were identified (Table 4).
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Table 4. Comparison of GöMP at Ellegaard and the University of Göttingen.
Virus Ellegaard 1 University Göttingen
PERV-A, PERV-B 40/40 (100%) 11/11 (100%)
PERV-C 28/28 (100%) 11/11 (100%)
HEV 9/40 (22.5%) 0/11 (0%)
PCMV 10/22 (45%) 0/11 (0%)
PLHV-1 1/10 (10%) 0/11 (0%)
PLHV-2 n.t. 0/11 (0%)
PLHV-3 n.t. 0/11 (0%)
PCV2 3/21 (14%) 2/11 (18%)
PCV3 0/10 (0%) 0/10 (0%)
1 Data from [6,11,12,16,19].
4. Discussion
This is the first extensive virological characterization of GöMPs breed isolated at the University of
Göttingen in comparison with the previously characterized GöMPs breed at Ellegaard. It is also the first
report showing a comprehensive strategy testing for 11 different xenotransplantation-relevant porcine
viruses in the donor pigs, including PERV-A, PERV-B, PERV-C and PERV-A/C as well as analyzing
transmission of human-tropic PERVs to human cells (Figure 1). This strategy is based on blood of
donor pigs.
Among the GöMP produced at Ellegaard HEV, PCMV, PCV2 and PLHV were found in a very small
number of animals [11,12] (Table 4) and it was shown that HEV was transmitted via the placenta [11].
It is interesting that the GöMP produced in Göttingen are free of PCMV, HEV, PLHV-1, PLHV-2,
PLHV-3, and PCV3. Either the infections with PCMV and HEV viruses happened at Ellegaard, or due
to the small number of animals investigated in Göttingen, PCMV-positive and HEV-positive animals
were missed. Infections could have happened during transport in containers used previously for other
pigs, or direct in the facility or by contaminated personal or material.
The data show that all GöMP in Göttingen contained PERV-A, PERV-B and PERV-C in their
genome. The presence of PERV-C is a prerequisite for recombinations with PERV-A, resulting in high
titer PERV-A/C recombinants [8,9]. Since PERV-A/C proviruses were already found in unstimulated
PBMCs, it is highly likely that these viruses can also be found in the living pig. In contrast, recombinant
PERV-A/Cs were not found in PBMCs from five Ellegaard pigs analyzed previously [6].
One of the main finding of this study is that PBMCs of only one from 11 GöMP from Göttingen
released a human-tropic PERV. This virus was identified as PERV-A/C (Figures 4 and 9). In parallel,
39 other pigs were analyzed using the same strategy including five Black forest Minipigs, five Aachen
Minipigs, 18 German Landrace and Large White cross-breeds and 5 others, none of them released a
human-tropic PERV able to infect 293 cells. Therefore, only one from 50 pigs released human-tropic
PERV [38]. In contrast to what has been published before [9,37], in the sequence of the recombinant
F-PERV there are two recombination points and an insertion of 15 nucleotides (Figure 9).
To evaluate the potential risk posed by PERVs is quite difficult. PERV-A, PERV-B and PERV-C are
integrated in the genome of all pigs, including the GöMP (Figure 3). PERV-A and PERV-B are able to
infect human cells, mainly human 293 cells lacking intracellular restriction factors [27]. In contrast
to this cell line, infection of human primary cells was achieved only with PERV passaged on human
cells [9,23,39]. Passaging the virus had resulted in additional repeats in the LTR and an increase of
the number of transcription factor binding sites and consequently in an increased replication rate [9].
At present, infection of 293 cells is thought to be the best assay to study the release of human-tropic
PERVs by pig cells [40]. This assay is widely accepted by regulatory agencies, but it is a complex,
expensive and time-consuming assay, especially if required at numerous stages in the process of
preparation of a transplant. In order to replace this assay, we suggested alternative assays based
on molecular biological methods [41]. One proposed assay is based on the detection of spliced
PERV-specific mRNA in mitogen-stimulated pig PBMCs, another is based on screening for PERV-A/C,
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since there are indications that only PERV-A/C are released from mitogen-activated PBMCs and infect
human cells.
Here we performed for the first time all assays in parallel. Using a PCR method, spliced mRNA
was only detected in cultured pig PBMCs regardless whether they were stimulated with PHA or
not (with exception of pig A), but not in freshly isolated PBMCs (Table 3). The culture in medium
with fetal calf serum (FCS) is certainly also associated with an immune stimulation of the pig PBMCs.
These preliminary data suggest that the detection of spliced mRNA is not a valuable marker for virus
release, but the detection of PERV-A/C is a good correlate to the release of infectious virus. Although
only one animal released a human-tropic PERV, the fact that it is a PERV-A/C supports previous
findings that only recombinant PERV-A/C are released from mitogen-stimulated PBMCs and that these
viruses are able to infect human 293 cells [25]. The situation may be different in the case of other
cells transplanted as part of solid organs or islet cells for the treatment of diabetes. The virus release
from stimulated PBMCs may represent a kind of worst-case scenario, which may not happen with
other cells.
In order to release virus, the cells should produce high amounts of mRNA required for protein
production and viral RNA to be packed into the virions. It is important to note, that the animal F, which
released a human-tropic PERV-A/C, had the highest expression of full- length mRNA and together
with animals A and I the highest expression PERV-C mRNA (Figure 6).
As mentioned above, only one of 11 GöMP from Göttingen released infectious PERV-A/C particles.
Higher expression of PERV and a higher prevalence of PERV-A/C have been linked with poor health
and disease in pigs in commercial swine operations [42]. However, the GöMP in Göttingen are
produced under highly hygienic conditions and therefore it is likely that the differences in PERV
expression and the release of PERV-A/C in one animal are not associated with infections, but with a
genetic trait. There is also no correlation with age (Table 1).
Stimulation of PBMCs from GöMP from Göttingen with a T cell mitogen, PHA-L, increased the
expression of PERV (Figure 7C,D). This confirms results with stimulated and unstimulated PBMCs
from GöMP from Ellegaard where an increase of PERVpol and PERV-C expression had been observed
on day 3 and day 5 compared with day 0 [6]. This also agrees with previous data showing that the
amount of released virus increased in the supernatant of stimulated PBMCs after 5 days [24]. Until now,
in all preclinical trials transplanting pig islet cells, kidneys and hearts to non-human primates no PERV
transmission was observed [43]. However, it has to be considered, that the PERV receptor in non-human
primates is mutated and therefore not fully functional. No transmission of PERV was also observed in
the first clinical trials, transplanting pig islet cells into diabetic patients in New Zealand and Argentina
under regulatory oversight [44,45]. At present there are no further experimental opportunities to
evaluate the potential risk posed by PERV until we move to the clinic [46]. On the other hand, there
were several attempts to reduce the risk of PERV transmission by reduction of the PERV expression
using PERV-specific siRNA in vitro and in vivo [47–52], by PERV-specific vaccines [53–56], antiviral
drugs (for review see [57]) and by genome editing. Whereas first attempts to inactivate multiple PERV
sequences in the pig genome using zinc finger nuclease failed [58], inactivation by CRISPR/Cas9 seemed
successful [21] and using this technology, healthy piglets with inactivated PERVs were generated [59].
Although until now no transmission of PERV to the recipients in all preclinical and clinical trials
was observed (for review see [60]), it is still unclear at present, whether genome edited animals should
be used for clinical xenotransplantation or whether PERV-C negative pigs will be safe enough [61–63].
Furthermore, transplanting islet cells from GöMP produced at Ellegaard into cynomolgus monkey
was also not associated with transmission of PERV or other porcine viruses [16]. A clinical study of
transplantation of islet cell from GöMP is planned in near future in Germany.
5. Conclusions
Using a new comprehensive strategy, a population of GöMP, which was bred isolated at the
University of Göttingen, was analyzed for the presence of 11 xenotransplantation-relevant porcine
Viruses 2020, 12, 38 16 of 19
viruses including PERV. This strategy tested GöMP for viruses by PCR, RT-PCR and immunological
methods. Furthermore, combining co-cultivation assays with susceptible human target cells and
molecular biological methods the expression and transmission of PERV was investigated. This strategy
was very effective in order to analyze the risk posed by PERV. The results show that the GöMP from the
Göttingen University are less contaminated with porcine viruses and therefore also suited for use in
clinical xenotransplantation after removal of the remaining viruses. The differences between GöMP at
the University of Göttingen and Ellegaard may be explained by selection of negative animals and/or de
novo infection. On the other hand, the GöMPs from Göttingen showed a higher prevalence of PERV-A/C
in their PBMCs and in one case release of an infectious human-tropic PERV-A/C was observed.
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